Search For "clinical trials"
Study finds patients with metastatic prostate cancer live notably longer
Updated : 3 years, 10 months ago IST
Salt Lake City (Utah) [US], May 3 (ANI): Researchers from SWOG Cancer Research Network have significantly extended median survival for patients with hormone-sensitive metastatic prostate cancer. This result comes from a large randomized clinical trial aimed at testing a new treatment for the
Read More
South Korea approves phase 3 clinical trials of breast cancer treatment 'T
Updated : 3 years, 11 months ago IST
Seoul [South Korea], April 19 (ANI/Global Economic): Phase 3 clinical trials of new breast cancer treatment approved in the U.S. and Europe will be conducted in Korea. The clinical trial is a global trial that will be conducted in multiple countries and is expected to be supplied in Korea as
Read More
Dr. Bharat Agravat creates Life-Saving Invention OSMF Mouth Opening Kit to
Updated : 3 years, 11 months ago IST
Ahmedabad (Gujarat) [India], March 21 (ANI/BusinessWire India): What People Didn't Know About the Link Between Oral Cancer and Oral Submucous Fibrosis.
Read More
Bharat Biotech's intranasal booster vaccine can be a game-changer if it pr
Updated : 4 years ago IST
New Delhi [India], March 11 (ANI): Bharat Biotech's intranasal booster vaccine can be a game-changer if it provides mucosal immunity against COVID-19, said Dr Sanjay Rai, Professor for Community Medicine at AIIMS as the clinical trials for the vaccine commenced on Friday.
Read More
Research finds COVID-19 vaccination benefits cancer patients
Updated : 4 years ago IST
Washington [US], March 11 (ANI): Cancer patients with compromised immune systems due to their disease or therapy remain at high risk for COVID-19 infection. While clinical trials showed vaccination could prevent or lessen the risk of severe illness in healthy individuals, it has been uncl
Read More
AIIMS Delhi to start clinical trial of intranasal COVID-19 vaccine from Fr
Updated : 4 years ago IST
New Delhi [India], March 9 (ANI): All India Institute of Medical Sciences (AIIMS) Delhi will start the clinical trials of Bharat Biotech's intranasal booster dose against COVID-19 from Friday, said sources.
Read More
COVID-19: FDA gives clearance to Covaxin for clinical trials in adults in
Updated : 4 years ago IST
New Delhi [India], March 7 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
Read More
Traditional Chinese Medicines ignore science, pose safety concerns, says r
Updated : 4 years ago IST
Beijing [China], February 15 (ANI): The presence of toxins in Traditional Chinese Medicines (TCM), their questionable clinical trials and lack of scientific evidence about their efficacy are raising many eyebrows.
Read More
Researchers restore function in gene that suppresses liver cancer, enhance
Updated : 4 years, 1 month ago IST
Boston [US], February 9 (ANI): Scientists and researchers never fail to amaze us with their dedication to making breakthrough discoveries that can save life even from life-threatening diseases. In a recent study, a team of researchers from Massachusetts General Hospital (MGH) and Brigham and
Read More
COVID-19: Nasal vaccine could be a game-changer if it provides mucosal imm
Updated : 4 years, 1 month ago IST
New Delhi [India], January 30 (ANI): As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sanjay
Read More
Bharat Biotech gets DCGI's nod to conduct intranasal booster dose trials
Updated : 4 years, 1 month ago IST
New Delhi [India], January 28 (ANI): The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.
Read More
Moderna says it has begun trial of Omicron-specific vaccine booster
Updated : 4 years, 1 month ago IST
Beijing [China], January 27 (ANI): Moderna, an American pharmaceutical and biotechnology company based in Cambridge on Wednesday (local time) announced that it has begun clinical trials of a booster dose of a vaccine designed specifically to combat the Omicron variant of COVID-19.
Read More